During the past decade, Temple University Health Sciences conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Temple University Health Sciences" #1 collaborator was "Basilea Pharmaceutica" with 1 trials as a collaborator and "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Temple University Health Sciences" are "Aspergillosis" (1 trials), "Candidemia" (1 trials), "Candidiasis, Invasive" (1 trials), "Invasive Fungal Infections" (1 trials) and "Mycoses" (1 trials). Many other conditions were trialed in "Temple University Health Sciences" in a lesser frequency.

Most popular intervention types in "Temple University Health Sciences" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Caspofungin" (1 trials), "Isavuconazole" (1 trials), "Voriconazole" (1 trials) and "isavuconazole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Temple University Health Sciences" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Temple University Health Sciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Temple University Health Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Temple University Health Sciences, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".